Skip to main content

Cervical Deformity

0
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Spine BioPharma
Spine BioPharmaNY - New York
3 programs
Prospective Radiographic and Clinical Evaluation of Surgical Treatment for Cervical DeformityN/A1 trial
Surgical interventionN/A
Symphony OCT SystemN/A1 trial
Active Trials
NCT01588054Completed100Est. Jun 2021
NCT04912674Active Not Recruiting100Est. Jul 2027
Orthofix International
Orthofix InternationalTX - Lewisville
1 program
Surgical interventionN/A1 trial
Active Trials
NCT04194996Recruiting200Est. Jul 2030

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Spine BioPharmaSymphony OCT System
Orthofix InternationalSurgical intervention
Spine BioPharmaProspective Radiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity

Clinical Trials (3)

Total enrollment: 400 patients across 3 trials

NCT04912674Spine BioPharmaSymphony OCT System

Evaluation of Symphony™ Posterior Cervical System for Surgical Treatment of Adult Cervical Deformity

Start: Jul 2021Est. completion: Jul 2027100 patients
N/AActive Not Recruiting
NCT04194996Orthofix InternationalSurgical intervention

Radiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity: A Multi-Center Study 2.0

Start: Aug 2019Est. completion: Jul 2030200 patients
N/ARecruiting
NCT01588054Spine BioPharmaProspective Radiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity

Prospective Radiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity

Start: Jan 2013Est. completion: Jun 2021100 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 400 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.